
US software company Glooko has just fetched USD 30m in a new financing round, according to a Tuesday press release. The firm is collaborating with Danish pharmaceutical Novo Nordisk on digital health solutions.
The technology company had a series D financing round led by Health Catalyst Capital with participation from existing investors such as Novo Nordisk.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app